Leflaw.com

You are here: Home

Defective Medical Devices

Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with ... - Genetic Engineering News

Tuesday, 03 August 2010 16:36

NATICK, Mass. , Aug. 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and ...

Source: http://www.genengnews.com/industry-updates/boston-scientific-begins-clinical-trial-enrollment-for-new-coronary-stent-with-bioabsorbable-pol/90386546/

Disclaimer

Effective 2010, Mr. Feldman is semi-retired and on inactive status, but is consulting or referring many matters to experienced counsel with which he has maintained longstanding relationships.

Defective Medical Devices

Defective Medical Devices News

Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with ... - Genetic Engineering News
Cardiovascular Systems Launches Diamondback Predator 360°™ PAD System - PR Inside
ZOLL Pittsburgh Facility Named Tech 50 Awards Finalist for Second Consecutive Year by ... - Business Wire
Epileptic Seizures Linked To Ancient Gene Family - Redorbit.com
Possible Link Between Epileptic Seizures And An Ancient Gene Family - Medical News Today